Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Jorge Belardi,
As Chairperson, we had four presentations reviewing the new definition of myocardial infarction, the impact on post PCI procedures, as well as the significance of CK and troponin elevation.
It was mentioned that, although CK-MB elevation five times has a significant impact on long-term mortality, times three is the cut-off value to be taken into consideration.
Although troponin elevation may be related to the outcome, the relation is not as clear as for CK.
The presentation by Dr Banning with insights from IVUS and MRI postulated two causes for biomarker elevation: side branch occlusions and embolization with impact on wall motion.
Dr Fajadet mentioned considerations for prevention following guidelines for medications such as dual antiplatelet and GP IIbIIIa in acute settings. He also mentioned possible causes to be presented such as dissection, side branch occlusion, collaterals and embolization. To conclude, he stated that patient selection and the risk related to the procedure have to be taken into account to avoid increased biomarkers and prevent necrosis during PCI.
The clinical relevance of myocardial necrosis during percutaneous coronary intervention
This congress report accompanies a presentation given at the ESC Congress 2008. Written by the author himself/herself, this report does not necessarily reflect the opinion of the European Society of Cardiology.
© 2017 European Society of Cardiology. All rights reserved